
New AMA data show limited insurer competition in commercial and Medicare Advantage markets, which can cut into physicians’ negotiating power and payment.
A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.
The






